Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Cardiovascular Effects of Zingiber Officinale as add-on Therapy in a Population of Type 2 Diabetes Individuals

NCT04222738 is registered in ClinicalTrials.gov with Yaounde Central Hospital as lead sponsor.

NCT NCT04222738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04222738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Cardiovascular Effects of Zingiber Officinale as add-on Therapy in a Population of Type 2 Diabetes Individuals
Lead sponsor
Yaounde Central Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 1, 2016
Completion date
May 31, 2017
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular benefits of zingiber officinale roscoe in patients with type 2 diabetes mellitus before and after 6 weeks of add-on therapy